Imaging Procedure:-15mCi 99mTcO-4 is administered IV 20 minutes after IV administration
of SnPyp (Stannous Pyrophosphate) for in-vitro RBC labeling. Imaging follows soon aftyer the injection.
Indications:
1. Evaluation of cardiac function in patients with non-specific symptoms.
2. Detection of coronary artery disease.
3. LV ejection fraction assessment.
4. Serial EF assesment in Patients cardiotoxic drugs.
5. In valvular heart disease-assesment of ionotropic function.
6. Hypertrophic cardiomyopathy.
7. Evaluation of cardiac function in patients of primary pulmonary disease.
(D) RESTING MUGA
Patient Preparation:- No special preparation required.
Duration:- 1 hr.